Advances in Biomarkers for Risk Stratification in Barrett ’s Esophagus

This report focuses only on those biomarkers that appear most promisi ng based on the availability of multiple published studies corroborating good results, and on the commercial availability of the test. These promising biomarkers include p53 immunostaining, TissueCypher, BarreGEN, and wide-area transepithelial sampling with computer-assisted 3-dimensional analysis ( WATS3D).
Source: Gastrointestinal Endoscopy Clinics of North America - Category: Gastroenterology Authors: Source Type: research